Bachem Holding AG is a prominent name in the biotechnology and pharmaceutical industry, specializing in the development and manufacture of peptides and oligonucleotides. These are complex organic comp... Bachem Holding AG is a prominent name in the biotechnology and pharmaceutical industry, specializing in the development and manufacture of peptides and oligonucleotides. These are complex organic compounds crucial for the creation of innovative therapeutics and diagnostics. Bachem's operations are integral to the pharmaceutical sector, providing specialist active pharmaceutical ingredients (APIs) and related services. The company's comprehensive offering includes full-spectrum support from initial research and development stages to full-scale production, underpinned by a commitment to quality and regulatory compliance. With a global presence, Bachem serves a wide array of clients across various pharmaceutical companies, ensuring the availability of critical components for drug development worldwide. Founded in 1971 and headquartered in Bubendorf, Switzerland, Bachem has established itself as a key player in facilitating advancements in medical treatments through its specialized biochemical expertise.
Pending data availability
Energy Management Data missing for Bachem Holding
We haven’t collected Energy Management data for Bachem Holding yet, or the company
hasn’t made it publicly available.